Moreover, according to MTT assay (Fig. 7D) and apoptosis analysis by flow cytometry (Figs. 7E–7F), decreased viability and in osteosarcoma cells treated with daidzein was partially reversed by overexpression of Src. The gene discussed is SRC; the disease is osteosarcoma.